1. Home
  2. NEWT vs PGEN Comparison

NEWT vs PGEN Comparison

Compare NEWT & PGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NEWT
  • PGEN
  • Stock Information
  • Founded
  • NEWT 1998
  • PGEN 1998
  • Country
  • NEWT United States
  • PGEN United States
  • Employees
  • NEWT N/A
  • PGEN N/A
  • Industry
  • NEWT Major Banks
  • PGEN Biotechnology: Pharmaceutical Preparations
  • Sector
  • NEWT Finance
  • PGEN Health Care
  • Exchange
  • NEWT Nasdaq
  • PGEN Nasdaq
  • Market Cap
  • NEWT 340.9M
  • PGEN 371.9M
  • IPO Year
  • NEWT N/A
  • PGEN N/A
  • Fundamental
  • Price
  • NEWT $13.02
  • PGEN $1.11
  • Analyst Decision
  • NEWT Hold
  • PGEN Buy
  • Analyst Count
  • NEWT 3
  • PGEN 5
  • Target Price
  • NEWT $14.67
  • PGEN $6.33
  • AVG Volume (30 Days)
  • NEWT 160.0K
  • PGEN 2.4M
  • Earning Date
  • NEWT 03-04-2025
  • PGEN 11-14-2024
  • Dividend Yield
  • NEWT 5.84%
  • PGEN N/A
  • EPS Growth
  • NEWT 22.62
  • PGEN N/A
  • EPS
  • NEWT 1.68
  • PGEN N/A
  • Revenue
  • NEWT $316,405,000.00
  • PGEN $3,963,000.00
  • Revenue This Year
  • NEWT N/A
  • PGEN N/A
  • Revenue Next Year
  • NEWT $8.51
  • PGEN $402.12
  • P/E Ratio
  • NEWT $7.75
  • PGEN N/A
  • Revenue Growth
  • NEWT 38.64
  • PGEN N/A
  • 52 Week Low
  • NEWT $10.07
  • PGEN $0.65
  • 52 Week High
  • NEWT $15.49
  • PGEN $1.93
  • Technical
  • Relative Strength Index (RSI)
  • NEWT 50.66
  • PGEN 58.19
  • Support Level
  • NEWT $12.52
  • PGEN $1.05
  • Resistance Level
  • NEWT $13.05
  • PGEN $1.46
  • Average True Range (ATR)
  • NEWT 0.33
  • PGEN 0.15
  • MACD
  • NEWT 0.06
  • PGEN 0.00
  • Stochastic Oscillator
  • NEWT 83.21
  • PGEN 54.55

About NEWT NewtekOne Inc.

NewtekOne Inc is a financial holding company engaged in providing financial solutions, It has developed a financial and technology-based business model that enables itself to acquire and process its clients in a very cost-effective manner. This capability is supported in large part by NewTracker, its patented prospect management technology software, that will allow NewtekOne clients to easily interact with NewtekOne subject matter experts in the areas of Banking, Lending, Payments, Technology, Payroll, and Insurance. It offers NewtekOne's clients a single online dashboard to access all of NewtekOne's business and financial solutions. It has four reportable segments Banking, Technology, NSBF, and Payments.

About PGEN Precigen Inc.

Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.

Share on Social Networks: